Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Triiodothyronine Reduces Vascular Dysfunction Associated with Hypertension by Attenuating Protein Kinase G/Vasodilator-Stimulated Phosphoprotein Signaling.

Carrillo-Sepulveda MA, Panackal A, Maracheril R, Maddie N, Patel MN, Ojamaa K, Savinova OV, Gerdes AM.

J Pharmacol Exp Ther. 2019 Oct;371(1):88-94. doi: 10.1124/jpet.119.260471. Epub 2019 Jul 12.

PMID:
31300610
2.

Physiology, Glucose Transporter Type 4 (GLUT4).

Vargas E, Podder V, Carrillo Sepulveda MA.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Aug 18.

3.

Western diet triggers Toll-like receptor 4 signaling-induced endothelial dysfunction in female Wistar rats.

Kramer B, França LM, Zhang Y, Paes AMA, Gerdes AM, Carrillo-Sepulveda MA.

Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1735-H1747. doi: 10.1152/ajpheart.00218.2018. Epub 2018 Sep 28.

4.

Biochemistry, Insulin Metabolic Effects.

Vargas E, Carrillo Sepulveda MA.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Apr 21.

5.

Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats.

Polce SA, Burke C, França LM, Kramer B, de Andrade Paes AM, Carrillo-Sepulveda MA.

Nutrients. 2018 Apr 25;10(5). pii: E531. doi: 10.3390/nu10050531.

6.

Comparison of Therapeutic Triiodothyronine Versus Metoprolol in the Treatment of Myocardial Infarction in Rats.

Zhang K, Tang YD, Zhang Y, Ojamaa K, Li Y, Saini AS, Carrillo-Sepulveda MA, Rajagopalan V, Gerdes AM.

Thyroid. 2018 Jun;28(6):799-810. doi: 10.1089/thy.2017.0544. Epub 2018 May 7.

7.

Ellagic Acid Reduces High Glucose-Induced Vascular Oxidative Stress Through ERK1/2/NOX4 Signaling Pathway.

Rozentsvit A, Vinokur K, Samuel S, Li Y, Gerdes AM, Carrillo-Sepulveda MA.

Cell Physiol Biochem. 2017;44(3):1174-1187. doi: 10.1159/000485448. Epub 2017 Nov 28.

8.

Triiodothyronine Potentiates Vasorelaxation via PKG/VASP Signaling in Vascular Smooth Muscle Cells.

Samuel S, Zhang K, Tang YD, Gerdes AM, Carrillo-Sepulveda MA.

Cell Physiol Biochem. 2017;41(5):1894-1904. doi: 10.1159/000471938. Epub 2017 Apr 4.

9.

The contribution of Toll-like receptors to placental inflammation in diet-induced maternal obesity.

Thompson JA, Hardigan TA, Carrillo-Sepulveda MA, Mintz JD, Ergul A, Diamond MP, Webb RC.

Placenta. 2015 Oct;36(10):1204-6. doi: 10.1016/j.placenta.2015.07.132. Epub 2015 Aug 6.

PMID:
26282853
10.

Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats.

Carrillo-Sepulveda MA, Spitler K, Pandey D, Berkowitz DE, Matsumoto T.

J Mol Med (Berl). 2015 Dec;93(12):1341-54. doi: 10.1007/s00109-015-1318-7. Epub 2015 Jul 17.

PMID:
26184970
11.

Erratum to: Activation of Toll-like receptor 3 increases mouse aortic vascular smooth muscle cell contractility through ERK1/2 pathway.

Hardigan T, Spitler K, Matsumoto T, Carrillo-Sepulveda MA.

Pflugers Arch. 2015 Nov;467(11):2387. doi: 10.1007/s00424-015-1706-4. No abstract available.

PMID:
25846382
12.

Activation of Toll-like receptor 3 increases mouse aortic vascular smooth muscle cell contractility through ERK1/2 pathway.

Hardigan T, Spitler K, Matsumoto T, Carrillo-Sepulveda MA.

Pflugers Arch. 2015 Nov;467(11):2375-85. doi: 10.1007/s00424-015-1697-1. Epub 2015 Mar 1. Erratum in: Pflugers Arch. 2015 Nov;467(11):2387.

PMID:
25724934
13.

Toll-like receptor 2 mediates vascular contraction and activates RhoA signaling in vascular smooth muscle cells from STZ-induced type 1 diabetic rats.

Schmidt L, Carrillo-Sepulveda MA.

Pflugers Arch. 2015 Nov;467(11):2361-74. doi: 10.1007/s00424-015-1688-2. Epub 2015 Jan 21.

PMID:
25600901
14.

Phenotypic modulation of mesenteric vascular smooth muscle cells from type 2 diabetic rats is associated with decreased caveolin-1 expression.

Carrillo-Sepulveda MA, Matsumoto T.

Cell Physiol Biochem. 2014;34(5):1497-506. doi: 10.1159/000366354. Epub 2014 Oct 9.

15.

Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension.

Carrillo-Sepulveda MA, Keen HL, Davis DR, Grobe JL, Sigmund CD.

PLoS One. 2014 Aug 14;9(8):e103786. doi: 10.1371/journal.pone.0103786. eCollection 2014.

16.

Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism.

Carrillo-Sepúlveda MA, Ceravolo GS, Furstenau CR, Monteiro Pde S, Bruno-Fortes Z, Carvalho MH, Laurindo FR, Tostes RC, Webb RC, Barreto-Chaves ML.

PLoS One. 2013 Apr 24;8(4):e61982. doi: 10.1371/journal.pone.0061982. Print 2013.

17.

Involvement of the AT1 receptor in the venoconstriction induced by angiotensin II in both the inferior vena cava and femoral vein.

da Silva OG, Rossignoli Pde S, Carrillo-Sepúlveda MA, Barreto-Chaves ML, Chies AB.

Peptides. 2011 Jan;32(1):112-7. doi: 10.1016/j.peptides.2010.10.010. Epub 2010 Oct 16.

PMID:
20955746
18.

The crosstalk between thyroid hormones and the Renin-Angiotensin System.

Barreto-Chaves ML, Carrillo-Sepúlveda MA, Carneiro-Ramos MS, Gomes DA, Diniz GP.

Vascul Pharmacol. 2010 Mar-Apr;52(3-4):166-70. doi: 10.1016/j.vph.2009.10.009. Epub 2009 Oct 24. Review.

PMID:
19857605
19.

Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes.

Carrillo-Sepúlveda MA, Ceravolo GS, Fortes ZB, Carvalho MH, Tostes RC, Laurindo FR, Webb RC, Barreto-Chaves ML.

Cardiovasc Res. 2010 Feb 1;85(3):560-70. doi: 10.1093/cvr/cvp304. Epub 2009 Sep 4.

20.

Activity and expression of ecto-5'-nucleotidase/CD73 are increased by thyroid hormones in vascular smooth muscle cells.

Tamajusuku AS, Carrillo-Sepúlveda MA, Braganhol E, Wink MR, Sarkis JJ, Barreto-Chaves ML, Battastini AM.

Mol Cell Biochem. 2006 Sep;289(1-2):65-72. Epub 2006 May 23.

PMID:
16718378

Supplemental Content

Loading ...
Support Center